Skip to main content
Erschienen in: Clinical Research in Cardiology 3/2017

26.09.2016 | Original Paper

Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension

verfasst von: Manuel J. Richter, Ralf Ewert, Christian Warnke, Henning Gall, Simon Classen, Friedrich Grimminger, Eckhard Mayer, Werner Seeger, Hossein-Ardeschir Ghofrani

Erschienen in: Clinical Research in Cardiology | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

In patients with severe pulmonary arterial hypertension, subcutaneous or catheter-based intravenous application of prostanoids carries a risk of local side effects or systemic infections, which limits their use and acceptance. Recently, a fully implantable pump for continuous application of intravenous treprostinil was approved in Germany. However, surgery is a major risk for patients with severe pulmonary arterial hypertension. The purpose of this study was to investigate the safety of a fully implantable pump inserted under local or general anesthesia in patients with severe pulmonary hypertension.

Methods

All patients with pulmonary hypertension undergoing pump implantation for the continuous application of intravenous treprostinil were included from two German centers. Surgery was performed under local or general anesthesia according to the protocol of the recruiting center. Intra-operative safety and in-hospital complications were analyzed for the two different implantation regimens.

Results

In total, 51 patients were included. No major intra-operative complications were recorded. During the observation period, two patients died of progressive right heart failure, and two patients required treatment in the intensive care unit for acute right heart decompensation and respiratory failure. In total, major complications occurred in 8 out of 51 patients.

Conclusions

Our observational study provides preliminary evidence supporting the procedural safety of a fully implantable pump inserted under local or general anesthesia for patients with severe pulmonary hypertension. The observation of major complications in a subset of patients requires extensive pre- and post-operative assessments. Future trials are required to provide further evidence for the long-term safety and efficacy of the pump using this approach.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62(25 Suppl):D34–D41. doi:10.1016/j.jacc.2013.10.029 CrossRefPubMed Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62(25 Suppl):D34–D41. doi:10.​1016/​j.​jacc.​2013.​10.​029 CrossRefPubMed
3.
Zurück zum Zitat Galie N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, McGoon MD, McLaughlin VV, Preston IR, Rubin LJ, Sandoval J, Seeger W, Keogh A (2013) Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol 62(25 Suppl):D60–D72. doi:10.1016/j.jacc.2013.10.031 CrossRefPubMed Galie N, Corris PA, Frost A, Girgis RE, Granton J, Jing ZC, Klepetko W, McGoon MD, McLaughlin VV, Preston IR, Rubin LJ, Sandoval J, Seeger W, Keogh A (2013) Updated treatment algorithm of pulmonary arterial hypertension. J Am Coll Cardiol 62(25 Suppl):D60–D72. doi:10.​1016/​j.​jacc.​2013.​10.​031 CrossRefPubMed
4.
Zurück zum Zitat Task Force for D, Treatment of Pulmonary Hypertension of European Society of C, European Respiratory S, International Society of H, Lung T, Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34(6):1219–1263. doi:10.1183/09031936.00139009 Task Force for D, Treatment of Pulmonary Hypertension of European Society of C, European Respiratory S, International Society of H, Lung T, Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34(6):1219–1263. doi:10.​1183/​09031936.​00139009
6.
Zurück zum Zitat Authors/Task Force M, Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M (2015) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. doi:10.1093/eurheartj/ehv317 Authors/Task Force M, Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M (2015) 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. doi:10.​1093/​eurheartj/​ehv317
7.
Zurück zum Zitat Hoeper MM, Gall H, Seyfarth HJ, Halank M, Ghofrani HA, Winkler J, Golpon H, Olsson KM, Nickel N, Opitz C, Ewert R (2009) Long-term outcome with intravenous iloprost in pulmonary arterial hypertension. Eur Respir J 34(1):132–137. doi:10.1183/09031936.00130408 CrossRefPubMed Hoeper MM, Gall H, Seyfarth HJ, Halank M, Ghofrani HA, Winkler J, Golpon H, Olsson KM, Nickel N, Opitz C, Ewert R (2009) Long-term outcome with intravenous iloprost in pulmonary arterial hypertension. Eur Respir J 34(1):132–137. doi:10.​1183/​09031936.​00130408 CrossRefPubMed
8.
Zurück zum Zitat Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, Keogh A, Oudiz R, Frost A, Blackburn SD, Crow JW, Rubin LJ (2002) Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 165(6):800–804. doi:10.1164/ajrccm.165.6.2106079 CrossRefPubMed Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, Keogh A, Oudiz R, Frost A, Blackburn SD, Crow JW, Rubin LJ (2002) Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 165(6):800–804. doi:10.​1164/​ajrccm.​165.​6.​2106079 CrossRefPubMed
9.
Zurück zum Zitat McLaughlin VV, Gaine SP, Barst RJ, Oudiz RJ, Bourge RC, Frost A, Robbins IM, Tapson VF, McGoon MD, Badesch DB, Sigman J, Roscigno R, Blackburn SD, Arneson C, Rubin LJ, Rich S, Treprostinil Study G (2003) Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension. J Cardiovasc Pharmacol 41(2):293–299 McLaughlin VV, Gaine SP, Barst RJ, Oudiz RJ, Bourge RC, Frost A, Robbins IM, Tapson VF, McGoon MD, Badesch DB, Sigman J, Roscigno R, Blackburn SD, Arneson C, Rubin LJ, Rich S, Treprostinil Study G (2003) Efficacy and safety of treprostinil: an epoprostenol analog for primary pulmonary hypertension. J Cardiovasc Pharmacol 41(2):293–299
10.
Zurück zum Zitat Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Clayton LM, Jobsis MM, Blackburn SD, Shortino D, Crow JW, Primary Pulmonary Hypertension Study G (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 334(5):296–301. doi:10.1056/NEJM199602013340504 Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, Groves BM, Tapson VF, Bourge RC, Brundage BH, Koerner SK, Langleben D, Keller CA, Murali S, Uretsky BF, Clayton LM, Jobsis MM, Blackburn SD, Shortino D, Crow JW, Primary Pulmonary Hypertension Study G (1996) A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 334(5):296–301. doi:10.​1056/​NEJM199602013340​504
11.
Zurück zum Zitat Frantz RP, Schilz RJ, Chakinala MM, Badesch DB, Frost AE, McLaughlin VV, Barst RJ, Rosenberg DM, Miller DP, Hartline BK, Benton WW, Farber HW (2014) Hospitalization and survival in patients utilizing epoprostenol for injection in the PROSPECT observational study. Chest. doi:10.1378/chest.14-1004 PubMedCentral Frantz RP, Schilz RJ, Chakinala MM, Badesch DB, Frost AE, McLaughlin VV, Barst RJ, Rosenberg DM, Miller DP, Hartline BK, Benton WW, Farber HW (2014) Hospitalization and survival in patients utilizing epoprostenol for injection in the PROSPECT observational study. Chest. doi:10.​1378/​chest.​14-1004 PubMedCentral
12.
Zurück zum Zitat Sitbon O, Jais X, Savale L, Cottin V, Bergot E, Macari EA, Bouvaist H, Dauphin C, Picard F, Bulifon S, Montani D, Humbert M, Simonneau G (2014) Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study. Eur Respir J 43(6):1691–1697. doi:10.1183/09031936.00116313 CrossRefPubMed Sitbon O, Jais X, Savale L, Cottin V, Bergot E, Macari EA, Bouvaist H, Dauphin C, Picard F, Bulifon S, Montani D, Humbert M, Simonneau G (2014) Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study. Eur Respir J 43(6):1691–1697. doi:10.​1183/​09031936.​00116313 CrossRefPubMed
14.
Zurück zum Zitat Rich JD, Glassner C, Wade M, Coslet S, Arneson C, Doran A, Gomberg-Maitland M (2012) The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension. Chest 141(1):36–42. doi:10.1378/chest.11-0245 CrossRefPubMed Rich JD, Glassner C, Wade M, Coslet S, Arneson C, Doran A, Gomberg-Maitland M (2012) The effect of diluent pH on bloodstream infection rates in patients receiving IV treprostinil for pulmonary arterial hypertension. Chest 141(1):36–42. doi:10.​1378/​chest.​11-0245 CrossRefPubMed
15.
Zurück zum Zitat Keusch S, Speich R, Treder U, Ulrich Somaini S (2013) Central venous catheter infections in outpatients with pulmonary hypertension treated with continuous iloprost. Respir Int Rev Thorac Dis 86(5):402–406. doi:10.1159/000350441 Keusch S, Speich R, Treder U, Ulrich Somaini S (2013) Central venous catheter infections in outpatients with pulmonary hypertension treated with continuous iloprost. Respir Int Rev Thorac Dis 86(5):402–406. doi:10.​1159/​000350441
16.
Zurück zum Zitat Kingman MS, Tankersley MA, Lombardi S, Spence S, Torres F, Chin KS, Prostacyclin Safety G (2010) Prostacyclin administration errors in pulmonary arterial hypertension patients admitted to hospitals in the United States: a national survey. J Heart Lung Transpl Off Publ Int Soc Heart Transpl 29(8):841–846. doi:10.1016/j.healun.2010.03.008 CrossRef Kingman MS, Tankersley MA, Lombardi S, Spence S, Torres F, Chin KS, Prostacyclin Safety G (2010) Prostacyclin administration errors in pulmonary arterial hypertension patients admitted to hospitals in the United States: a national survey. J Heart Lung Transpl Off Publ Int Soc Heart Transpl 29(8):841–846. doi:10.​1016/​j.​healun.​2010.​03.​008 CrossRef
17.
18.
Zurück zum Zitat Desole S, Velik-Salchner C, Fraedrich G, Ewert R, Kahler CM (2012) Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension. Heart Lung J Crit Care 41(6):599–605. doi:10.1016/j.hrtlng.2012.07.001 CrossRef Desole S, Velik-Salchner C, Fraedrich G, Ewert R, Kahler CM (2012) Subcutaneous implantation of a new intravenous pump system for prostacyclin treatment in patients with pulmonary arterial hypertension. Heart Lung J Crit Care 41(6):599–605. doi:10.​1016/​j.​hrtlng.​2012.​07.​001 CrossRef
19.
Zurück zum Zitat Bourge RC, Waxman AB, Gomberg-Maitland M, Shapiro SM, Tarver IIIJH, Zwicke DL, Feldman JP, Chakinala MM, Frantz RP, Torres F, Cerkvenik J, Morris M, Thalin M, Peterson L, Rubin LJ (2016) Treprostinil administered to treat pulmonary artery hypertension using a fully implantable programmable intravascular delivery system: results of the delivery for pah trial. Chest. doi:10.1016/j.chest.2015.11.005 PubMed Bourge RC, Waxman AB, Gomberg-Maitland M, Shapiro SM, Tarver IIIJH, Zwicke DL, Feldman JP, Chakinala MM, Frantz RP, Torres F, Cerkvenik J, Morris M, Thalin M, Peterson L, Rubin LJ (2016) Treprostinil administered to treat pulmonary artery hypertension using a fully implantable programmable intravascular delivery system: results of the delivery for pah trial. Chest. doi:10.​1016/​j.​chest.​2015.​11.​005 PubMed
21.
Zurück zum Zitat Sammut D, Elliot CA, Kiely DG, Armstrong IJ, Martin L, Wilkinson J, Sephton P, Jones J, Hamilton N, Hurdman J, McLellan E, Sabroe I, Condliffe R (2013) Central venous catheter-related blood stream infections in patients receiving intravenous iloprost for pulmonary hypertension. Eur J Clin Microbiol Infect Dis 32(7):883–889. doi:10.1007/s10096-013-1822-z CrossRefPubMed Sammut D, Elliot CA, Kiely DG, Armstrong IJ, Martin L, Wilkinson J, Sephton P, Jones J, Hamilton N, Hurdman J, McLellan E, Sabroe I, Condliffe R (2013) Central venous catheter-related blood stream infections in patients receiving intravenous iloprost for pulmonary hypertension. Eur J Clin Microbiol Infect Dis 32(7):883–889. doi:10.​1007/​s10096-013-1822-z CrossRefPubMed
22.
Zurück zum Zitat Plumhans C, Mahnken AH, Ocklenburg C, Keil S, Behrendt FF, Gunther RW, Schoth F (2011) Jugular versus subclavian totally implantable access ports: catheter position, complications and intrainterventional pain perception. Eur J Radiol 79(3):338–342. doi:10.1016/j.ejrad.2009.12.010 CrossRefPubMed Plumhans C, Mahnken AH, Ocklenburg C, Keil S, Behrendt FF, Gunther RW, Schoth F (2011) Jugular versus subclavian totally implantable access ports: catheter position, complications and intrainterventional pain perception. Eur J Radiol 79(3):338–342. doi:10.​1016/​j.​ejrad.​2009.​12.​010 CrossRefPubMed
23.
Zurück zum Zitat Mudan S, Giakoustidis A, Morrison D, Iosifidou S, Raobaikady R, Neofytou K, Stebbing J (2015) 1000 Port-A-Cath (R) placements by subclavian vein approach: single surgeon experience. World J Surg 39(2):328–334. doi:10.1007/s00268-014-2802-x CrossRefPubMed Mudan S, Giakoustidis A, Morrison D, Iosifidou S, Raobaikady R, Neofytou K, Stebbing J (2015) 1000 Port-A-Cath (R) placements by subclavian vein approach: single surgeon experience. World J Surg 39(2):328–334. doi:10.​1007/​s00268-014-2802-x CrossRefPubMed
24.
Zurück zum Zitat Apsner R, Schulenburg A, Sunder-Plassmann G, Muhm M, Keil F, Malzer R, Kalhs P, Druml W (1998) Routine fluoroscopic guidance is not required for placement of Hickman catheters via the supraclavicular route. Bone Marrow Transpl 21(11):1149–1152. doi:10.1038/sj.bmt.1701250 CrossRef Apsner R, Schulenburg A, Sunder-Plassmann G, Muhm M, Keil F, Malzer R, Kalhs P, Druml W (1998) Routine fluoroscopic guidance is not required for placement of Hickman catheters via the supraclavicular route. Bone Marrow Transpl 21(11):1149–1152. doi:10.​1038/​sj.​bmt.​1701250 CrossRef
25.
Zurück zum Zitat Blaise G, Langleben D, Hubert B (2003) Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology 99(6):1415–1432CrossRefPubMed Blaise G, Langleben D, Hubert B (2003) Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology 99(6):1415–1432CrossRefPubMed
26.
Zurück zum Zitat Fischer LG, Van Aken H, Burkle H (2003) Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesth Analg 96(6):1603–1616CrossRefPubMed Fischer LG, Van Aken H, Burkle H (2003) Management of pulmonary hypertension: physiological and pharmacological considerations for anesthesiologists. Anesth Analg 96(6):1603–1616CrossRefPubMed
27.
Zurück zum Zitat Meyer S, McLaughlin VV, Seyfarth HJ, Bull TM, Vizza CD, Gomberg-Maitland M, Preston IR, Barbera JA, Hassoun PM, Halank M, Jais X, Nickel N, Hoeper MM, Humbert M (2013) Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. Eur Respir J 41(6):1302–1307. doi:10.1183/09031936.00089212 CrossRefPubMed Meyer S, McLaughlin VV, Seyfarth HJ, Bull TM, Vizza CD, Gomberg-Maitland M, Preston IR, Barbera JA, Hassoun PM, Halank M, Jais X, Nickel N, Hoeper MM, Humbert M (2013) Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. Eur Respir J 41(6):1302–1307. doi:10.​1183/​09031936.​00089212 CrossRefPubMed
29.
Zurück zum Zitat Busch CA, Shore BJ, Bhandari R, Ganapathy S, MacDonald SJ, Bourne RB, Rorabeck CH, McCalden RW (2006) Efficacy of periarticular multimodal drug injection in total knee arthroplasty. A randomized trial. J Bone Joint Surg Am 88(5):959–963. doi:10.2106/JBJS.E.00344 Busch CA, Shore BJ, Bhandari R, Ganapathy S, MacDonald SJ, Bourne RB, Rorabeck CH, McCalden RW (2006) Efficacy of periarticular multimodal drug injection in total knee arthroplasty. A randomized trial. J Bone Joint Surg Am 88(5):959–963. doi:10.​2106/​JBJS.​E.​00344
30.
Zurück zum Zitat Vendittoli PA, Makinen P, Drolet P, Lavigne M, Fallaha M, Guertin MC, Varin F (2006) A multimodal analgesia protocol for total knee arthroplasty. A randomized, controlled study. J Bone Joint Surg Am 88(2):282–289. doi:10.2106/JBJS.E.00173 Vendittoli PA, Makinen P, Drolet P, Lavigne M, Fallaha M, Guertin MC, Varin F (2006) A multimodal analgesia protocol for total knee arthroplasty. A randomized, controlled study. J Bone Joint Surg Am 88(2):282–289. doi:10.​2106/​JBJS.​E.​00173
31.
32.
Zurück zum Zitat Stempien L, Tsai T (2000) Intrathecal baclofen pump use for spasticity: a clinical survey. Am J Phys Med Rehabil 79(6):536–541CrossRefPubMed Stempien L, Tsai T (2000) Intrathecal baclofen pump use for spasticity: a clinical survey. Am J Phys Med Rehabil 79(6):536–541CrossRefPubMed
33.
Zurück zum Zitat Doran AK, Ivy DD, Barst RJ, Hill N, Murali S, Benza RL (2008) Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension. Int J Clin Pract Suppl 160:5–9. doi:10.1111/j.1742-1241.2008.01811.x CrossRef Doran AK, Ivy DD, Barst RJ, Hill N, Murali S, Benza RL (2008) Guidelines for the prevention of central venous catheter-related blood stream infections with prostanoid therapy for pulmonary arterial hypertension. Int J Clin Pract Suppl 160:5–9. doi:10.​1111/​j.​1742-1241.​2008.​01811.​x CrossRef
34.
Zurück zum Zitat Oudiz RJ, Widlitz A, Beckmann XJ, Camanga D, Alfie J, Brundage BH, Barst RJ (2004) Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension. Chest 126(1):90–94. doi:10.1378/chest.126.1.90 CrossRefPubMed Oudiz RJ, Widlitz A, Beckmann XJ, Camanga D, Alfie J, Brundage BH, Barst RJ (2004) Micrococcus-associated central venous catheter infection in patients with pulmonary arterial hypertension. Chest 126(1):90–94. doi:10.​1378/​chest.​126.​1.​90 CrossRefPubMed
35.
Zurück zum Zitat Ray S, Stacey R, Imrie M, Filshie J (1996) A review of 560 Hickman catheter insertions. Anaesthesia 51(10):981–985CrossRefPubMed Ray S, Stacey R, Imrie M, Filshie J (1996) A review of 560 Hickman catheter insertions. Anaesthesia 51(10):981–985CrossRefPubMed
Metadaten
Titel
Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension
verfasst von
Manuel J. Richter
Ralf Ewert
Christian Warnke
Henning Gall
Simon Classen
Friedrich Grimminger
Eckhard Mayer
Werner Seeger
Hossein-Ardeschir Ghofrani
Publikationsdatum
26.09.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Research in Cardiology / Ausgabe 3/2017
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI
https://doi.org/10.1007/s00392-016-1037-2

Weitere Artikel der Ausgabe 3/2017

Clinical Research in Cardiology 3/2017 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.